Health authorities in England are launching a vaccination campaign offering meningitis B protection to approximately one million young people. The initiative follows a significant outbreak in Kent that resulted in 29 confirmed or suspected cases and two deaths in March. Nearly 90,000 doses have already been administered, with an additional 135,000 appointments scheduled for the coming weeks.
The vaccine is being offered to 17 and 18-year-olds in sixth form, as well as students under age 25 entering residential university or college settings for the first time this autumn. Eligible groups include those born between 1 September 2007 and 31 August 2008, plus first-time university and residential college students born on or after 21 July 2001. International students and those from other UK nations studying in England also qualify. The vaccine consists of two doses administered at least 28 days apart for full protection.
Bookings can be made through high street pharmacies across England, with walk-in services available for those meeting age and enrollment criteria. Seventeen and 18-year-olds can book via the NHS National Booking Service if registered with a GP. The vaccine poses minimal risk, with common side effects including mild injection site reactions and temporary fever or headache that typically resolve within one to two days.
Meningitis B can cause serious complications including inflammation of the brain lining and blood poisoning, potentially resulting in permanent disabilities or death. First-year university students face approximately seven times higher infection risk compared to non-university peers of similar age, partly due to increased social mixing and shared living arrangements. The disease spreads through close contact such as kissing and sharing items. Vaccine experts now recommend consideration of routine vaccination for all teenagers around age 15, pending government approval in each UK nation.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI